Company Overview and News

0
Banco Products (I) Limited - Dividend

2018-05-30 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
500039 BANCOINDIA

0
Banco Products (I) Limited - Disc. under Reg.30 of SEBI (SAST) Reg.2011

2018-04-04 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
500039 BANCOINDIA

0
Banco Products (I) Limited - Trading Window

2018-03-31 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
500039 BANCOINDIA

0
Banco Products (I) Limited - Dividend

2018-03-20 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
500039 BANCOINDIA

0
Banco Products (I) Limited - Record Date

2018-03-16 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
500039 BANCOINDIA

14
Market Live: Nifty breaks 10,200, Sensex sinks 500 pts; all sectoral indices in the red

2018-03-16 moneycontrol
2:50 pm Market Update: Benchmark indices fell sharply in last hour of trade amid political upheaval after the Telugu Desam Party (TDP) formally decided to quit the NDA government.
513262 500325 GOACARBON JIPKY 532915 RELIANCE IDBI RELIGARE HNDZY HDFC 533278 RIGD 500010 CLNDY 509488 GRAVITA RLNIY 509567 YESBANK 500039 EDELWEISS 500116 GRAPHITE 533282 JPASSOCIAT 532648 YYBKY 532922 BANCOINDIA 532843 ZENSARTECH 532532 504067 FORTIS HDFC COALINDIA SSWL 500188 HINDZINC

14
Market Live: Sensex slips 300 pts, Nifty below 10,300; PSU Bank index outshines

2018-03-16 moneycontrol
1:54 pm Market Update: The market was trading near day's low as benchmark indices declined nearly 1 percent each by intense selling in heavyweights - Reliance Industries, HDFC twins, ITC.
513262 500325 GOACARBON JIPKY 532915 RELIANCE IDBI RELIGARE HNDZY 533278 RIGD CLNDY 509488 GRAVITA RLNIY 509567 YESBANK 500039 EDELWEISS 500116 GRAPHITE 533282 JPASSOCIAT 532648 YYBKY 532922 BANCOINDIA 532843 ZENSARTECH 532532 504067 FORTIS COALINDIA SSWL 500188 HINDZINC

14
Market Live: Sensex slips 300 pts, Nifty below 10,300; HDFC, RIL, ITC, Tata Motors drag

2018-03-16 moneycontrol
engine-powered ATR aircraft of IndiGo's maiden flight from Toulouse to New Delhi was aborted and had to return to the French facility due to low oil pressure.
JIPKY 532915 IDBI RELIGARE HNDZY 533278 500570 TATAMOTORS CLNDY 509488 GRAVITA YESBANK 500039 EDELWEISS 500116 GRAPHITE 533282 JPASSOCIAT 532648 YYBKY 532922 BANCOINDIA 532843 ZENSARTECH 532532 504067 FORTIS COALINDIA 500188 HINDZINC TTM

0
Banco Products (I) Limited - Dividend

2018-03-16 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
500039 BANCOINDIA

Related Articles

CASC: Cascadian Therapeutics Analysis and Research Report

1h - Asif

Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...

BAC: Bank of America Corp. Analysis and Research Report

2h - Asif

Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...